December 24, 2025
According to market projections, the pharmaceutical CDMO sector is expected to grow from USD 167.96 billion in 2025 to USD 337.89 billion by 2035, reflecting a CAGR of 7.24%. Pharma companies face challenges in researching and manufacturing new thera...
February 06, 2026
The U.S. pharmaceutical CDMO market size is calculated at USD 39.13 bn in 2025 is to hit USD 72.98 bn by 2035. The U.S. Pharmaceutical CDMO market is evolving with key developments in 2024. Recipharm partnered with Exela Pharma for sterile manufactur...
January 27, 2026
The Europe pharmaceutical CDMO market size is calculated at $37.98 bn in 2025 is to hit $ 74.99 bn by 2035. In 2024, Germany led the European pharmaceutical CDMO market, with France expected to experience the fastest growth. The API segment dominated...
February 11, 2026
Based on our estimations, the pharmaceutical CRO and CDMO market was valued at USD 254.65 billion in 2025 and is estimated to reach USD 277.16 billion in 2026, with the market projected to expand to USD 594.07 billion by 2035, registering a CAGR of 8...
November 01, 2025
According to forecasts, the global active pharmaceutical ingredients CDMO market will grow from USD 127.45 billion in 2024 to USD 260.98 billion by 2034, with an expected CAGR of 7.43%. In 2024, Asia-Pacific led the global API market, while North Ame...
October 27, 2025
Based on market forecasts, the global pharmaceutical grade melatonin market, projected at USD 479.9 million in 2024, is expected to reach USD 1044.3 million by 2034, growing at a CAGR of 8.56% over the forecast period. The rising prevalence of sleep ...
November 17, 2025
Market insights predict the U.S. pharmaceutical industry will increase from USD 520.4 billion in 2025 to USD 965 billion by 2035, achieving a CAGR of 6.37%. The strong presence of pharmaceutical companies and favorable regulatory support bolsters mar...
October 08, 2025
Market insights predict the North America pharmaceutical industry will increase from USD 601.17 billion in 2024 to USD 1043.48 billion by 2034, achieving a CAGR of 5.67%. The continued innovations and high healthcare spending in potential pharmaceuti...
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
October 07, 2025
Market insights predict, the APAC pharmaceutical industry is expected to grow from USD 434.19 billion in 2024 to USD 855.68 billion by 2034, driven by a CAGR of 7.02%. The rising prevalence of chronic disorders and the increasing need for personalize...
October 08, 2025
Market insights predict, the Middle East and Africa pharmaceutical industry is expected to grow from USD 75.15 billion in 2024 to USD 141.3 billion by 2034, driven by a CAGR of 6.52%. This market is rising due to increasing chronic disease prevalence...
February 11, 2026
Market insights predict the global pharmaceutical excipients industry will increase from USD 10.83 billion in 2025 to USD 16.12 billion by 2035, achieving a CAGR of 4.06%. Pharmaceutical excipients, though meant to be inert, can sometimes cause react...
January 28, 2026
According to market projections, the pharmaceutical filtration sector is expected to grow from USD 14.95 billion in 2025 to USD 32.51 billion by 2035, reflecting a CAGR of 8.08%. Globally, there is a growing need for generic medications due to the si...
November 01, 2025
Market insights predict, the U.S. pharmaceutical water industry is expected to grow from USD 7.11 billion in 2024 to USD 17.04 billion by 2034, driven by a CAGR of 8.94%. Rising demand for injectable drugs, vaccines, biologics, and biosimilars, which...
November 01, 2025
According to forecasts, the global pharmaceutical spray drying market will grow from USD 2.37 billion in 2024 to USD 4.93 billion by 2034, with an expected CAGR of 7.67%. The pharmaceutical spray drying market is expanding due to growing drug develop...
November 01, 2025
Based on market forecasts, the global pharmaceutical secondary packaging market, projected at USD 43.11 billion in 2024, is expected to reach USD 69.45 billion by 2034, growing at a CAGR of 4.94% over the forecast period. Rising demand for drugs and ...
January 19, 2026
Market insights predict the global pharmaceutical industry will increase from USD 1772.65 billion in 2025 to USD 3219.76 billion by 2035, achieving a CAGR of 6.15%. The pharmaceutical industry is growing strongly due to the growing geriatric populati...
November 01, 2025
Market insights predict, the biotechnology & pharmaceutical services industry is expected to grow from USD 76.51 billion in 2024 to USD 130.56 billion by 2034, driven by a CAGR of 5.48%. Globally, accelerating technological advancements in ...
October 13, 2025
The AI-based pharmaceutical R&D services market is growing due to rising demand for automation. North America’s dominance can be attributed to the rising R&D in developing novel therapeutics....
February 18, 2026
According to market projections, the pharmaceutical testing services sector is expected to grow from USD 4.72 billion in 2025 to USD 12.86 billion by 2035, reflecting a CAGR of 10.54%.Due to accelerating heavy investments in R&D and demand for ...
November 01, 2025
According to market estimations, the pharmaceutical water market is projected to grow at a robust CAGR of 9.25% from 2024 to 2034. North America led with a 35% market share in 2023, while Asia Pacific is anticipated to expand at the fastest rate of 1...
January 06, 2026
According to forecasts, the global medical membrane market will grow from USD 4.58 billion in 2025 to USD 9.39 billion by 2035, with an expected CAGR of 7.45%. The growing usage of medical membranes in tissue engineering, microfiltration, advanced dr...
November 25, 2025
According to forecasts, the global pharmaceutical packaging market will grow from USD 167.88 billion in 2025 to USD 425.25 billion by 2035, with an expected CAGR of 9.74%. The demand for pharmaceutical packaging is directly associated with the growin...
February 05, 2026
Based on our estimations, the pharmaceutical electronic distribution market was valued at USD 70.27 billion in 2025 and is projected to reach USD 76.27 billion in 2026, expanding to approximately USD 159.46 billion by 2035 at a CAGR of 8.54% during 2...
October 10, 2025
Market insights predict the global Latin America pharmaceutical industry will increase from USD 91.85 billion in 2024 to USD 172.71 billion by 2034, achieving a CAGR of 6.52%. The market is expanding due to the rising prevalence of chronic diseases, ...
February 24, 2026
Based on our estimations, the valves in pharmaceutical market was valued at USD 2.48 billion in 2025 and is expected to grow from USD 2.62 billion in 2026 to USD 4.37 billion by 2035, expanding at a CAGR of 5.84% (2026–2035)....
November 01, 2025
Market insights predict, the ready to use pharmaceutical packaging market industry is expected to grow from USD 10.4 billion in 2024 to USD 20.97 billion by 2034, driven by a CAGR of 7.24%. The ready-to-use pharmaceutical packaging market is increasi...
February 04, 2026
According to forecasts, the global active pharmaceutical ingredients market will grow from USD 219.7 billion in 2025 to USD 418.64 billion by 2035, with an expected CAGR of 6.66%. In 2022, North America led the global active pharmaceutical ingredient...
February 10, 2026
According to our insight calculates, the membrane technology in the pharmaceutical market was valued at USD 2.66 billion in 2026 and is projected to reach USD 4.43 billion by 2035, growing at a CAGR of 5.85% from 2026 to 2035....
November 01, 2025
Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standa...
January 29, 2026
According to our projections, the biotechnology and pharmaceutical services outsourcing market was valued at USD 51.59 billion in 2025 and reached USD 54.54 billion in 2026, and it is projected to grow to USD 89.82 billion by 2035, registering a CAGR...
February 16, 2026
Based on our market research, the protein degradation therapy market was valued at USD 1.57 billion in 2026 and is projected to reach USD 2.74 billion by 2035, expanding at a CAGR of 6.34% (2026–2035) from a 2025 base of USD 1.48 billion....
November 01, 2025
Based on market forecasts, the global pharmaceutical logistic market, projected at USD 111.45 million in 2024, is expected to reach USD 191.1 million by 2034, growing at a CAGR of 5.54% over the forecast period. The demand for efficient and timely de...
December 26, 2025
Projections indicate that, the global cleanroom technologies market will increase from USD 9.47 billion in 2025 to USD 18.35 billion by 2035, experiencing a CAGR of 6.84% over the next 10 years. The cleanroom technologies market is expanding due to...
November 01, 2025
The adoption of advanced filtration technologies to boost the product quality, purity, and safety, as well as the growing demand for diverse biologics, vaccines are fueling the global market growth. North America led the market due to the expansion...
February 20, 2026
Our projections indicate that, the pharmaceutical contract manufacturing and research services market was valued at USD 281.68 billion in 2025 and is projected to reach USD 301.23 billion in 2026, further expanding to USD 551.01 billion by 2035, grow...
November 01, 2025
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
November 01, 2025
According to forecasts, the global pharmaceutical drying equipment market will grow from USD 5.84 billion in 2024 to USD 11.64 billion by 2034, with an expected CAGR of 7.14%. Rising demand for biologics and vaccines is estimated to drive the growt...
February 19, 2026
According to our projections, the high potency active pharmaceutical ingredients market was valued at USD 30.86 billion in 2025 and reached USD 33.45 billion in 2026, and is projected to grow significantly to USD 69.13 billion by 2035, expanding at a...
November 01, 2025
According to market projections, the global pharmaceutical metal detector market, valued at USD 160.04 million in 2024, is anticipated to reach USD 252.66 million by 2034, growing at a CAGR of 4.67% over the next decade. The pharmaceutical metal de...
November 01, 2025
According to market projections, the global pharmaceutical inspection machines market, valued at USD 0.96 billion in 2024, is anticipated to reach USD 1.96 billion by 2034, growing at a CAGR of 7.56% over the next decade. The market is growing due ...
December 26, 2025
Market insights predict the global biopharmaceutical CDMO industry will increase from USD 20.55 billion in 2024 to USD 46.98 billion by 2034, achieving a CAGR of 8.73%. The biopharmaceutical CDMO market is expanding due to growth in research and deve...
February 04, 2026
Based on our research, the healthcare CDMO market was valued at USD 306.3 billion in 2025 and reached USD 337.3 billion in 2026, and it is projected to expand to USD 803.17 billion by 2035, growing at a CAGR of 10.12% during 2026–2035....
February 13, 2026
According to our projections, the mRNA CDMO service market was valued at USD 5.53 billion in 2025 and reached USD 5.94 billion in 2026, and it is projected to grow to USD 11.25 billion by 2035, expanding at a CAGR of 7.36% during 2026–2035....
October 17, 2025
The global AAV vector CDMO services market was valued at USD 9.84 billion in 2024 and is projected to reach USD 25.36 billion by 2034, growing at a CAGR of 9.75%. North America led with 38% share, followed by Europe (29%) and Asia-Pacific (23%). The ...
November 01, 2025
Forecasts suggest that the small molecule CDMO market will expand from USD 72.81 billion in 2024 to USD 145.12 billion by 2034, with a CAGR of 7.14% during this period. In 2024, North America led the small molecule CDMO market, with APIs holding the ...
January 07, 2026
Projections indicate that, the Cell and Gene Therapy Services Market was valued at USD 10.79 billion in 2025 and is projected to grow from USD 11.84 billion in 2026 to USD 27.16 billion by 2035, registering a CAGR of 9.67% during 2026–2035. The...
January 13, 2026
The antibiotic CDMO market is growing because it provides services and support to antibiotic manufacturers from drug discovery to manufacturing, with comprehensive services. North America is dominant in the market due to advancements in manufacturing...
October 03, 2025
Market insights predict the global biotechnology CMO and CDMO industry will increase from USD 67.25 billion in 2024 to USD 199.67 billion by 2034, achieving a CAGR of 11.54%. The biotechnology CMO and CDMO market is growing because these services hel...
November 26, 2025
Market insights predict the global oncolytic virus CDMO services industry will increase from USD 419.51 million in 2025 to USD 1734.41 million by 2035, achieving a CAGR of 15.25%. Rising cancer prevalence globally, increasing demand for innovative th...
November 01, 2025
Market insights predict the global biologics CDMO industry will increase from USD 22 billion in 2024 to USD 92.79 billion by 2034, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expect...
November 01, 2025
According to market projections, the viral vector-based cell & gene therapy CDMO sector is expected to grow from USD 142.77 million in 2024 to USD 497.7 million by 2034, reflecting a CAGR of 13.44%. The key benefits of collaborating with a viral ...
November 01, 2025
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.0...
January 21, 2026
Based on our market research, the global medical device CMO and CDMO industry will increase from USD 48.39 billion in 2025 to USD 110.82 billion by 2035, achieving a CAGR of 8.64%....
November 01, 2025
The CDMO aseptic filling solutions market is growing due to strict regulations implemented by governments to ensure patient safety. North America is leading the market due to the growing demand for biologics and growing research in the biopharmaceuti...
November 01, 2025
Based on market forecasts, the oligonucleotide CDMO sector will expand from USD 2.55 billion in 2024 to USD 18.37 billion by 2034, experiencing a CAGR of 21.83%. In 2024, North America led the oligonucleotide CDMO market, with Asia Pacific poised for...
November 06, 2025
Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.17 billion in 2024 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal h...
November 01, 2025
Based on market forecasts, the cell and gene therapy CDMO sector will expand from USD 6.41 billion in 2024 to USD 75.32 billion by 2034, experiencing a CAGR of 27.94%. In 2024, North America led the cell and gene therapy CDMO market with a 41% share,...
November 01, 2025
Based on forecasts, the CDMO services for pharma and biotech market is expanding due to increasing outsourcing as well as rising cancer treatment approaches. North America led the market due to the presence of well-developed industries. ...
November 01, 2025
According to market projections, the bioconjugation sector is expected to grow from USD 5.52 billion in 2024 to USD 23.18 billion by 2034, reflecting a CAGR of 15.46%. Bioconjugation is playing a vital role in next-generation diagnostic tools such as...
October 10, 2025
According to market projections, the new chemical entities (NCE) CDMO sector is expected to grow from USD 2.65 billion in 2024 to USD 7.83 billion by 2034, reflecting a CAGR of 11.44%. The new chemical entities (NCE) CDMO market is growing due to its...
December 30, 2025
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
February 18, 2026
According to our forecasts, the microbial CDMO market was valued at USD 3.96 billion in 2025 and reached USD 4.3 billion in 2026, and is projected to grow to USD 9.15 billion by 2035, expanding at a CAGR of 8.74% (2026–2035)....
February 17, 2026
According to our forecasts, the drug delivery CDMO market is set for strong growth from 2026 to 2035, driven by rising chronic diseases, expanding biologics and GLP-1 therapies, and increasing outsourcing by pharmaceutical and biotech companies....
October 08, 2025
Based on market forecasts, the mRNA therapeutics CDMO sector will expand from USD 4.62 billion in 2024 to USD 13.63 billion by 2034, experiencing a CAGR of 11.37%.The growing demand for vaccines and the rising prevalence of chronic disorders drive th...
February 27, 2026
Our projections indicate, the small molecule CMO and CDMO market was valued at USD 75.8 billion in 2025 and is projected to grow from USD 79.7 billion in 2026 to USD 125.13 billion by 2035, expanding at a CAGR of 5.14% during 2026–2035....
February 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.5...
February 24, 2026
According to our projections, the U.S. life science sector is expected to grow from USD 31.58 billion in 2025 to USD 98.52 billion by 2035, reflecting a CAGR of 12.05%. The U.S. life science market is growing strong due to the rising demand for biolo...
February 23, 2026
Based on our estimations, the U.S. small molecule innovator API CDMO market was valued at USD 9.37 billion in 2025 and reached USD 9.94 billion in 2026, and is projected to grow to USD 16.85 billion by 2035, expanding at a CAGR of 6.04% from 2026 to ...
November 01, 2025
The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approache...
November 01, 2025
Based on market forecasts, the global advanced therapy medicinal products CDMO market, projected at USD 6.73 billion in 2024, is expected to reach USD 37.27 billion by 2034, growing at a CAGR of 18.82% over the forecast period. The global market is d...
January 19, 2026
According to market projections, the generic pharmaceuticals sector is expected to grow from USD 460.47 billion in 2025 to USD 1026.8 billion by 2035, reflecting a CAGR of 8.35%. The rise in patent expiration, increasing demand for cost-effective and...
December 30, 2025
The biopharmaceuticals market size is calculated at $ 474.28 bn in 2025 is to hit $1540.14 bn by 2035. The biopharmaceuticals market is growing rapidly, driven by advances in biologics, personalized medicine, and gene therapy. Innovations in monoclon...
October 14, 2025
The global marine pharmaceuticals market was valued at USD 6.19 B in 2024 and is projected to reach USD 10.34 B by 2034 at a 5.29% CAGR. Covers NA, EU, APAC, LA, MEA, with full segmentation, trade, manufacturer, and supplier data. Regional data acr...
October 29, 2025
According to forecasts, the global AI in biopharmaceuticals market will grow from USD 1.55 billion in 2024 to USD 24.49 billion by 2034, with an expected CAGR of 32.27%. The implementation of artificial intelligence in biotechnology and pharmaceutica...
November 01, 2025
The biopharmaceuticals CRO market is expanding due to increasing diseases as well as rising clinical trials. North America led the market due to the presence of well-developed biopharmaceutical industries....
November 01, 2025
Market insights predict, the cell and gene therapy (CGT) pharmaceuticals industry is expected to grow from USD 16.75 billion in 2024 to USD 91.56 billion by 2034, driven by a CAGR of 18.93%. The growing demand for personalized medicine, driving patie...
November 11, 2025
Market insights predict the global old chain pharmaceuticals industry will increase from USD 6.67 billion in 2025 to USD 9.71 billion by 2035, achieving a CAGR of 3.83%. The cold chain pharmaceuticals market is expanding due to the increasing use of ...
December 23, 2025
According to market projections, the PEGylated proteins sector is expected to grow from USD 1.63 billion in 2024 to USD 4.95 billion by 2034, reflecting a CAGR of 11.74%. In 2024, North America led the PEGylated proteins market with a 35% share, whil...
November 01, 2025
Market insights predict, the radiopharmaceutical industry is expected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034, driven by a CAGR of 7.57%. The research in radiopharmaceuticals is introducing new approaches that enhance the sp...
November 01, 2025
Projections indicate that, companion animal health industry is projected to rise from USD 25.28 billion in 2024 to USD 61.74 billion by 2034, reflecting a CAGR of 9.34% over the next decade. In 2024, North America led the companion animal health mark...
February 06, 2026
According to our forecasts, the radiopharmaceutical for nuclear medicine market was valued at USD 8.43 billion in 2026 and is projected to reach USD 17.91 billion by 2035, growing at a CAGR of 8.74% during the forecast period....
November 01, 2025
According to market projections, the biopharmaceutical third-Party logistics sector is expected to grow from USD 143.44 billion in 2024 to USD 276.24 billion by 2034, reflecting a CAGR of 6.62%. The market is growing due to rising global demand...
November 24, 2025
Projections indicate that, AI in pharmaceuticals industry is projected to rise from USD 1.97 billion in 2025 to USD 21.51 billion by 2035, reflecting a CAGR of 27.01% over the next decade. The AI in the pharmaceutical market is growing as demand for ...
November 01, 2025
Based on market forecasts, the plasmid purification sector will expand from USD 1.95 billion in 2024 to USD 5.88 billion by 2034, experiencing a CAGR of 11.64%. In 2024, North America led the plasmid purification market with a 41% share, while Asia P...
November 01, 2025
The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector....
November 04, 2025
According to market projections, the global generic pharmaceuticals contract manufacturing market, valued at USD 81.24 billion in 2025, is anticipated to reach USD 143.22 billion by 2035, growing at a CAGR of 5.85% over the next decade. Day by day, t...
November 01, 2025
According to market projections, the theranostics sector is expected to grow from USD 2.42 billion in 2024 to USD 10.21 billion by 2034, reflecting a CAGR of 15.46%. Technological advancements and boosting non-oncological applications are driving the...
December 01, 2025
Market insights predict, the U.S. biopharmaceutical third-party logistics industry is expected to grow from USD 61.08 billion in 2025 to USD 127.06 billion by 2035, driven by a CAGR of 7.6%. Rising complexities and volume of biopharmaceutical product...
November 01, 2025
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
November 03, 2025
Based on market forecasts, the microcarriers sector will expand from USD 1.76 billion in 2024 to USD 5.21 billion by 2034, experiencing a CAGR of 11.48%.The microcarriers market is growing due to they are broadly applied in medical regeneration, in...
November 01, 2025
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com